Building Development-Ready Nasal Combination Products: Lessons Learned from Advancing a Powder-Based Emergency Therapy
4:30 pm - Wednesday 3rd February 2027
- Understand how early integration of formulation development with device design and manufacturing capacities while meeting regulatory requirements can prevent costly late-stage redesigns, delays, and regulatory setbacks
- Explore the key development challenges associated with advancing powder-based combination products, including device reliability requirements, human factors trials, clinical development planning, and regulatory expectations
- Learn how teams can build commercially viable intranasal products by integrating patient, payer, and provider perspectives into target product profiles
